Quantcast

VCU Medical Center First In Virginia To Implant Miniature Telescope For Macular Degeneration

April 16, 2013
Image Caption: Implantable telescope technology reduces the impact of the central vision blind spot due to End-Stage AMD. The telescope implant projects the objects the patient is looking at onto the healthy area of the light-sensing retina not degenerated by the disease. Credit: Virginia Commonwealth University

Virginia Commonwealth University

Implant improves vision for patients suffering from the leading cause of blindness in older Americans.

The telescope implant is designed to correct end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans. Patients with end-stage AMD have a central blind spot. This vision loss makes it difficult or impossible to see faces, to read and to perform everyday activities such as watching television, preparing meals and self-care.

William H. Benson, M.D., a cornea specialist and chairman of the Department of Ophthalmology at the VCU School of Medicine, performed the procedure.

“We are excited to provide this new surgical option to our advanced macular degeneration patients, who up until now have had limited options for improving vision,” Benson said. “Advanced macular degeneration is a devastating disease, which cannot be treated by any available drugs or surgical procedures. The telescope implant offers a new hope for patients with limited vision.”

Smaller than a pea, the telescope implant uses micro-optical technology to magnify images that would normally be seen in one´s “straight ahead” or central vision. The images are projected onto the healthy portion of the retina not affected by the disease, making it possible for patients to see or discern the central vision object of interest.

The Implantable Miniature Telescope (By Dr. Isaac Lipshitz) is a product of VisionCare Ophthalmic Technologies, Inc.

On The Net:


Source: Virginia Commonwealth University



comments powered by Disqus